Compare Edwards Lifesciences Corporation Common Stock (EW) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs NOV Inc. Common Stock — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while NOV Inc. Common Stock trades at $19.08 (market cap $6.64B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7.4× NOV Inc. Common Stock's market cap, and NOV Inc. Common Stock pays a 1.93% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | NOV | |
|---|---|---|
Market Cap | $49.44B | $6.64B |
Volume | 3,508,027 | 4,238,905 |
Sector | Health | Energy |
52-Week High | $95.18 | $21.71 |
52-Week Low | $72.65 | $12.31 |
Enterprise Value | $45.90B | $7.80B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 1.93% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
